Home
Cancer Biomarkers
NF1 Mutation
Details
33 Trials
0 Therapies
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma
Venetoclax, Busulfan, Cladribine, and Fludarabine for the Treatment of High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)